Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Lowsky

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 23, 2019
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 TrialSergio Giralt, Luciano J Costa, David Maloney, et al.
Bone Marrow Transplantation|June 24, 2021
Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myelomaChristopher Lemieux, Lori S Muffly, David J Iberri, et al.
Blood Advances|August 21, 2019
Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohortMichael A Spinner, Vanessa E Kennedy, John S Tamaresis, et al.
Blood Advances|January 4, 2018
HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activityMichael A Spinner, Marcelo Fernández-Viña, Lisa E Creary, et al.
Transplantation and Cellular Therapy|August 29, 2025
The Impact of Anti-CD38 Monoclonal Antibody Therapy on Stem-Cell Mobilization Yields in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Referred from Community and Academic Oncology Practices: Single Center, Real World Data 2021-2024Dilek Uzun, Jeddeo Michael Paul, Alexandria Jensen, et al.
JCI Insight|May 17, 2019
Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipientsEverett H Meyer, Ginna Laport, Bryan J Xie, et al.
Transplantation and Cellular Therapy|March 27, 2026
Superior Chronic GVHD-Free Survival with Post-Transplant Cyclophosphamide Relative to Tacrolimus/Methotrexate in Myeloablative HLA-Matched Allogeneic Hematopoietic Cell TransplantationAlfonso Molina, Quenton Rashawn Bubb, Hrishikesh K Srinagesh, et al.
Blood Cancer Journal|October 9, 2024
Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myelomaSurbhi Sidana, Andriyana K Bankova, Hitomi Hosoya, et al.
Blood Advances|August 23, 2021
Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemiaLori Muffly, Vandana Sundaram, Connie Chen, et al.
Bone Marrow Transplantation|December 19, 2023
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository studyPhilip L McCarthy, Kristopher M Attwood, Xiaojun Liu, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 23, 2019
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 TrialSergio Giralt, Luciano J Costa, David Maloney, et al.
Bone Marrow Transplantation|June 24, 2021
Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myelomaChristopher Lemieux, Lori S Muffly, David J Iberri, et al.
Blood Advances|August 21, 2019
Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohortMichael A Spinner, Vanessa E Kennedy, John S Tamaresis, et al.
Blood Advances|January 4, 2018
HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activityMichael A Spinner, Marcelo Fernández-Viña, Lisa E Creary, et al.
Transplantation and Cellular Therapy|August 29, 2025
The Impact of Anti-CD38 Monoclonal Antibody Therapy on Stem-Cell Mobilization Yields in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Referred from Community and Academic Oncology Practices: Single Center, Real World Data 2021-2024Dilek Uzun, Jeddeo Michael Paul, Alexandria Jensen, et al.
JCI Insight|May 17, 2019
Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipientsEverett H Meyer, Ginna Laport, Bryan J Xie, et al.
Transplantation and Cellular Therapy|March 27, 2026
Superior Chronic GVHD-Free Survival with Post-Transplant Cyclophosphamide Relative to Tacrolimus/Methotrexate in Myeloablative HLA-Matched Allogeneic Hematopoietic Cell TransplantationAlfonso Molina, Quenton Rashawn Bubb, Hrishikesh K Srinagesh, et al.
Blood Cancer Journal|October 9, 2024
Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myelomaSurbhi Sidana, Andriyana K Bankova, Hitomi Hosoya, et al.
Blood Advances|August 23, 2021
Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemiaLori Muffly, Vandana Sundaram, Connie Chen, et al.
Bone Marrow Transplantation|December 19, 2023
Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository studyPhilip L McCarthy, Kristopher M Attwood, Xiaojun Liu, et al.
Pageof 7